Status:
COMPLETED
Anecortave Acetate for Treatment of Steroid Induced Intraocular Pressure (IOP) Elevation
Lead Sponsor:
Alcon Research
Conditions:
Eye Diseases
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and efficacy of anecortave acetate depot when administered for the treatment of elevated IOP following treatment with steroids.
Eligibility Criteria
Inclusion
- Either gender
- 18 years of age or older
- IOP elevation caused by steroid usage
- Other protocol-defined inclusion criteria may apply
Exclusion
- Under 18 years of age
- Other protocol-defined exclusion criteria may apply
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2009
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00315640
Start Date
December 1 2005
End Date
July 1 2009
Last Update
November 28 2012
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Jacksonville
Jacksonville, Florida, United States, 32204
2
Miami
Miami, Florida, United States, 33136
3
Detroit
Detroit, Michigan, United States, 48202
4
Fort Worth, Texas, United States, 76134